All Posts

Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases

There are no cures for neurodegenerative protein conformational diseases (PCDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). Emerging evidence suggests the gut microbiota plays a role in their pathogenesis, though the influences of specific bacteria on disease-associated proteins remain elusive.

Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices

Test-negative designs are increasingly used to evaluate vaccine effectiveness because of desirable properties like reduced confounding due to healthcare-seeking behaviors and lower cost compared to other study designs. An individual’s decision to seek care often depends on their disease severity, with severe disease more likely to be captured than mild disease.

Engineered In Vitro Models to Improve the Mechanistic Understanding and Treatment of Neglected Tropical Diseases Caused by Protozoan Parasites

Neglected tropical diseases (NTDs), particularly those caused by trypanosomatid protozoa, impose a significant global burden, disproportionately affecting underserved communities in tropical and subtropical regions. Despite their high mortality rates, associated chronic conditions, and rapid spread due to globalization and climate change, NTDs have historically received minimal research investment.

Persistence of Daptomycin-Resistant and Vancomycin-Resistant Enterococci in Hospitalized Patients with Underlying Malignancies: A 7-Year Follow-Up Study

Vancomycin-resistant enterococci (VRE) are a major cause of healthcare-associated infections, with an estimated 54,500 cases among hospitalized patients and 5400 deaths per year associated with VRE in the United States alone. In particular, patients with underlying hematologic malignancies such as leukemia and patients undergoing hematopoietic cell transplant (HCT) and solid organ transplant are at higher risk for VRE acquisition and infections due to their weakened immune system and multiple courses of antibiotics.